128 related articles for article (PubMed ID: 29181185)
1. Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis.
Tominaga H; Setoguchi T; Shimada H; Nagano S; Sasaki H; Ishidou Y; Sato M; Mizuno K; Inoue H; Komiya S
Mol Clin Oncol; 2017 Nov; 7(5):897-902. PubMed ID: 29181185
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
3. Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.
Nagata M; Kudoh S; Mitsuoka S; Suzumura T; Umekawa K; Tanaka H; Matsuura K; Kimura T; Yoshimura N; Hirata K
Osaka City Med J; 2013 Jun; 59(1):45-52. PubMed ID: 23909080
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis.
Kang EJ; Lee SY; Kim HJ; Min KH; Hur GY; Shim JJ; Kang KH; Oh SC; Seo JH; Lee SY; Kim JS
Oncology; 2016; 90(2):103-11. PubMed ID: 26785048
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis.
Bae HM; Lee SH; Kim TM; Kim DW; Yang SC; Wu HG; Kim YW; Heo DS
Lung Cancer; 2012 Sep; 77(3):572-7. PubMed ID: 22672969
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
7. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
8. Prediction of skeletal-related events in patients with non-small cell lung cancer.
Aiba H; Kimura T; Yamagami T; Watanabe N; Sakurai H; Kimura H; Shimozaki S; Yamada S; Otsuka T
Support Care Cancer; 2016 Aug; 24(8):3361-7. PubMed ID: 26980332
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer.
Imura Y; Tateiwa D; Sugimoto N; Inoue A; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Yagi T; Naka N; Okawa S; Tabuchi T; Takenaka S
Mol Clin Oncol; 2020 Oct; 13(4):31. PubMed ID: 32765878
[TBL] [Abstract][Full Text] [Related]
10. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
da Silva GT; Bergmann A; Thuler LCS
Support Care Cancer; 2016 Feb; 24(2):731-736. PubMed ID: 26143039
[TBL] [Abstract][Full Text] [Related]
11. Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis.
Pruksakorn D; Phanphaisarn A; Settakorn J; Arpornchayanon U; Tantraworasin A; Chaiyawat P; Klangjorhor J; Teeyakasem P
J Bone Oncol; 2018 Mar; 10():1-5. PubMed ID: 29321965
[TBL] [Abstract][Full Text] [Related]
12. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
[TBL] [Abstract][Full Text] [Related]
13. Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.
Lipton A; Fizazi K; Stopeck AT; Henry DH; Smith MR; Shore N; Martin M; Vadhan-Raj S; Brown JE; Richardson GE; Saad F; Yardley DA; Zhou K; Balakumaran A; Braun A
Eur J Cancer; 2016 Jan; 53():75-83. PubMed ID: 26693901
[TBL] [Abstract][Full Text] [Related]
14. Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases.
Sun JM; Ahn JS; Lee S; Kim JA; Lee J; Park YH; Park HC; Ahn MJ; Ahn YC; Park K
Lung Cancer; 2011 Jan; 71(1):89-93. PubMed ID: 20598769
[TBL] [Abstract][Full Text] [Related]
15. Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers.
Meng C; Wei J; Tian J; Ma J; Liu N; Yuan Z; Zhao L; Wang P
J Bone Oncol; 2021 Dec; 31():100394. PubMed ID: 34703756
[TBL] [Abstract][Full Text] [Related]
16. Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.
Langer C; Hirsh V
Lung Cancer; 2010 Jan; 67(1):4-11. PubMed ID: 19939491
[TBL] [Abstract][Full Text] [Related]
17. Adrenalectomy does not improve survival rates of patients with solitary adrenal metastasis from non-small cell lung cancer.
Huang SH; Kong QL; Chen XX; He JY; Qin J; Chen ZG
Ther Clin Risk Manag; 2017; 13():355-360. PubMed ID: 28356749
[TBL] [Abstract][Full Text] [Related]
18. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
[TBL] [Abstract][Full Text] [Related]
19. The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
Botticelli A; Cirillo A; Scagnoli S; Cerbelli B; Strigari L; Cortellini A; Pizzuti L; Vici P; De Galitiis F; Di Pietro FR; Cerbelli E; Ghidini M; D'Amati G; Della Rocca C; Mezi S; Gelibter A; Giusti R; Cortesi E; Ascierto PA; Nuti M; Marchetti P
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32353934
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
Tanaka R; Yonemori K; Hirakawa A; Kinoshita F; Takahashi N; Hashimoto J; Kodaira M; Yamamoto H; Yunokawa M; Shimizu C; Fujimoto M; Fujiwara Y; Tamura K
Oncologist; 2016 Apr; 21(4):508-13. PubMed ID: 26975863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
